These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3518682)

  • 1. Long-term ocular manifestations in nephropathic cystinosis.
    Kaiser-Kupfer MI; Caruso RC; Minkler DS; Gahl WA
    Arch Ophthalmol; 1986 May; 104(5):706-11. PubMed ID: 3518682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestations of nephropathic cystinosis. The French-Canadian experience in a genetically homogeneous population.
    Richler M; Milot J; Quigley M; O'Regan S
    Arch Ophthalmol; 1991 Mar; 109(3):359-62. PubMed ID: 2003795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis.
    Kalatzis V; Serratrice N; Hippert C; Payet O; Arndt C; Cazevieille C; Maurice T; Hamel C; Malecaze F; Antignac C; Müller A; Kremer EJ
    Pediatr Res; 2007 Aug; 62(2):156-62. PubMed ID: 17597652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
    Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
    Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIH conference. Cystinosis: progress in a prototypic disease.
    Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
    Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of nephropathic cystinosis after renal failure.
    Gahl WA; Kaiser-Kupfer MI
    Pediatr Nephrol; 1987 Jul; 1(3):260-8. PubMed ID: 3153286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine.
    Dureau P; Broyer M; Dufier JL
    J Pediatr Ophthalmol Strabismus; 2003; 40(3):142-6. PubMed ID: 12795432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of topical cysteamine drops on reducing crystal formation within the cornea of patients affected by nephropathic cystinosis.
    MacDonald IM; Noel LP; Mintsioulis G; Clarke WN
    J Pediatr Ophthalmol Strabismus; 1990; 27(5):272-4. PubMed ID: 2246744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy.
    Tavares R; Coelho D; Macário MC; Torres A; Quadrado MJ; Murta J
    Cornea; 2009 Sep; 28(8):938-40. PubMed ID: 19654516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swallowing dysfunction in nephropathic cystinosis.
    Sonies BC; Ekman EF; Andersson HC; Adamson MD; Kaler SG; Markello TC; Gahl WA
    N Engl J Med; 1990 Aug; 323(9):565-70. PubMed ID: 2381441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis.
    Tsilou ET; Rubin BI; Reed GF; Iwata F; Gahl W; Kaiser-Kupfer MI
    Cornea; 2002 Mar; 21(2):173-6. PubMed ID: 11862089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular changes in long-term evolution of infantile cystinosis.
    Dufier JL; Dhermy P; Gubler MC; Gagnadoux MF; Broyer M
    Ophthalmic Paediatr Genet; 1987 Jun; 8(2):131-7. PubMed ID: 3658340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM; Monnens LA; Levtchenko EN
    Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classic nephropathic cystinosis as an adult disease.
    Theodoropoulos DS; Krasnewich D; Kaiser-Kupfer MI; Gahl WA
    JAMA; 1993 Nov; 270(18):2200-4. PubMed ID: 8411603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
    Gahl WA; Balog JZ; Kleta R
    Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal sensitivity in nephropathic cystinosis.
    Katz B; Melles RB; Schneider JA
    Am J Ophthalmol; 1987 Oct; 104(4):413-6. PubMed ID: 3661652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis.
    Wühl E; Haffner D; Gretz N; Offner G; van't Hoff WG; Broyer M; Mehls O
    Pediatr Res; 1998 Apr; 43(4 Pt 1):484-8. PubMed ID: 9545002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cystinosis: an infrequent cause of distal myopathy].
    Rodríguez-Gómez FJ; López-Domínguez JM; Borrero-Martín JJ; Rodríguez-Gómez E; Chinchón-Lara I; Pujol-De la Llave E
    Rev Neurol; 2005 Feb 1-15; 40(3):156-8. PubMed ID: 15750900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal myopathy in nephropathic cystinosis.
    Vester U; Schubert M; Offner G; Brodehl J
    Pediatr Nephrol; 2000 Jan; 14(1):36-8. PubMed ID: 10654328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Complications of Infantile Nephropathic Cystinosis.
    Bishop R
    J Pediatr; 2017 Apr; 183S():S19-S21. PubMed ID: 28343471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.